Invention Grant
- Patent Title: Hepatitis C virus NS3 protease inhibitors
- Patent Title (中): 丙型肝炎病毒NS3蛋白酶抑制剂
-
Application No.: US13387542Application Date: 2010-07-27
-
Publication No.: US08828930B2Publication Date: 2014-09-09
- Inventor: Nigel J. Liverton , John A. McCauley , Michael T. Rudd
- Applicant: Nigel J. Liverton , John A. McCauley , Michael T. Rudd
- Applicant Address: US NJ Rahway
- Assignee: Merck Sharp & Dohme Corp.
- Current Assignee: Merck Sharp & Dohme Corp.
- Current Assignee Address: US NJ Rahway
- Agent Sheldon O. Heber; Julie M. Lake
- International Application: PCT/US2010/043340 WO 20100727
- International Announcement: WO2011/014487 WO 20110203
- Main IPC: A61K38/00
- IPC: A61K38/00 ; A01N37/18
Abstract:
The present invention relates to macrocyclic compounds of Formula (I) that are useful as inhibitors of the hepatitis C virus (HCV) NS3 protease, their synthesis, and their use for treating or preventing HCV infections.
Public/Granted literature
- US20120121624A1 HEPATITIS C VIRUS NS3 PROTEASE INHIBITORS Public/Granted day:2012-05-17
Information query
IPC分类:
